Literature DB >> 26516462

Opioids and endocrine dysfunction.

Oliver Seyfried1, Joan Hester1.   

Abstract

The endocrine effects of opioids used for the management of persistent pain are poorly understood by clinicians and patients, and hormone levels are rarely measured. It is recognized that opioids exert this effect via the hypothalamic-pituitary-gonadal axis. Additional effects on adrenal hormones, weight, blood pressure and bone density may also occur. Symptoms and signs of sex hormone deficiency occur in both men and women but are under-reported and are often clinically unrecognized. The potential effects of long term opioid therapy on the endocrine system should be explained to patients before opioid therapy is commenced. Monitoring of sex hormones is recommended; if there are deficiencies opioids should be tapered and withdrawn, if this is clinically acceptable. If opioid therapy has to continue, hormone replacement therapy should be initiated and monitored by an endocrinologist.

Entities:  

Keywords:  Opioids; endocrine; hormone replacement; hypogonadism; sex hormones; testosterone

Year:  2012        PMID: 26516462      PMCID: PMC4590093          DOI: 10.1177/2049463712438299

Source DB:  PubMed          Journal:  Br J Pain        ISSN: 2049-4637


  22 in total

Review 1.  The health of normally aging men: The Massachusetts Male Aging Study (1987-2004).

Authors:  Amy B O'Donnell; Andre B Araujo; John B McKinlay
Journal:  Exp Gerontol       Date:  2004-07       Impact factor: 4.032

2.  Tramadol-induced hyponatremia.

Authors:  Damien Sarret; Jean-Philippe Le Berre; Nadir Zemraoui
Journal:  Am J Kidney Dis       Date:  2008-11       Impact factor: 8.860

3.  Sex hormone suppression by intrathecal opioids: a prospective study.

Authors:  Lindy J Roberts; Phillip M Finch; Peter T Pullan; Chotoo I Bhagat; Leanne M Price
Journal:  Clin J Pain       Date:  2002 May-Jun       Impact factor: 3.442

4.  DHEAS deficiency during consumption of sustained-action prescribed opioids: evidence for opioid-induced inhibition of adrenal androgen production.

Authors:  Harry W Daniell
Journal:  J Pain       Date:  2006-12       Impact factor: 5.820

Review 5.  The effects of opioids and opioid analogs on animal and human endocrine systems.

Authors:  Cassidy Vuong; Stan H M Van Uum; Laura E O'Dell; Kabirullah Lutfy; Theodore C Friedman
Journal:  Endocr Rev       Date:  2009-11-10       Impact factor: 19.871

6.  Hypogonadism and methadone: Hypothalamic hypogonadism after long-term use of high-dose methadone.

Authors:  R E de la Rosa; J V Hennessey
Journal:  Endocr Pract       Date:  1996 Jan-Feb       Impact factor: 3.443

7.  Impaired circadian rhythmicity of beta-lipotrophin, beta-endorphin and ACTH in heroin addicts.

Authors:  F Facchinetti; A Grasso; F Petraglia; D Parrini; A Volpe; A R Genazzani
Journal:  Acta Endocrinol (Copenh)       Date:  1984-02

8.  Intrathecal opioid treatment for chronic non-malignant pain: a 3-year prospective study.

Authors:  Mark A Thimineur; Edward Kravitz; Mohan S Vodapally
Journal:  Pain       Date:  2004-06       Impact factor: 6.961

Review 9.  The impact of opioids on the endocrine system.

Authors:  Nathaniel Katz; Norman A Mazer
Journal:  Clin J Pain       Date:  2009-02       Impact factor: 3.442

10.  Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain.

Authors:  Harry W Daniell
Journal:  J Pain       Date:  2007-11-01       Impact factor: 5.820

View more
  18 in total

Review 1.  New Developments in the Psychological Management of Chronic Pain.

Authors:  Stephen Morley; Amanda Williams
Journal:  Can J Psychiatry       Date:  2015-04       Impact factor: 4.356

2.  Endometriosis-associated pain syndrome: a nurse-led approach.

Authors:  Julia Cambitzi; Maya Nagaratnam
Journal:  Br J Pain       Date:  2013-02

Review 3.  Pain in the Frail or Elderly Patient: Does Tapentadol Have a Role?

Authors:  Felicity C Veal; Gregory M Peterson
Journal:  Drugs Aging       Date:  2015-06       Impact factor: 3.923

4.  Examining patterns in opioid prescribing for non-cancer-related pain in Wales: preliminary data from a retrospective cross-sectional study using large datasets.

Authors:  Emma Davies; Ceri Phillips; Jaynie Rance; Berni Sewell
Journal:  Br J Pain       Date:  2018-09-25

5.  Comparison of implant survivability in primary 1- to 2-level lumbar fusion amongst opioid abusers and non-opioid abusers.

Authors:  Rushabh M Vakharia; Chester J Donnally; Augustus J Rush; Ajit M Vakharia; Derek D Berglund; Neil V Shah; Michael Y Wang
Journal:  J Spine Surg       Date:  2018-09

6.  Opioids Cause Sex-Specific Vascular Changes via Cofilin-Extracellular Signal-Regulated Kinase Signaling: Female Mice Present Higher Risk of Developing Morphine-Induced Vascular Dysfunction than Male Mice.

Authors:  Soyoung Cheon; Jeremy C Tomcho; Jonnelle M Edwards; Nicole R Bearss; Emily Waigi; Bina Joe; Cameron G McCarthy; Camilla F Wenceslau
Journal:  J Vasc Res       Date:  2021-09-14       Impact factor: 2.045

7.  Tramadol Induced Adrenal Insufficiency: Histological, Immunohistochemical, Ultrastructural, and Biochemical Genetic Experimental Study.

Authors:  Shereen Abdelhakim Abdelaleem; Osama A Hassan; Rasha F Ahmed; Nagwa M Zenhom; Rehab A Rifaai; Nashwa F El-Tahawy
Journal:  J Toxicol       Date:  2017-11-27

8.  'ReConnect': a model for working with persistent pain patients on improving sexual relationships.

Authors:  Sarah Edwards; Anna Mandeville; Katrine Petersen; Julia Cambitzi; Amanda C de C Williams; Katherine Herron
Journal:  Br J Pain       Date:  2019-06-10

9.  Suprascapular nerve block is a clinically attractive alternative to interscalene nerve block during arthroscopic shoulder surgery: a meta-analysis of randomized controlled trials.

Authors:  Xu Cai; Huadong Yang; Changjiao Sun; Xiaolin Ji; Xiaofei Zhang; Qi Ma; Peng Yu
Journal:  J Orthop Surg Res       Date:  2021-06-11       Impact factor: 2.359

Review 10.  Recent advances in cancer pain management.

Authors:  James Wilson; Catherine Stack; Joan Hester
Journal:  F1000Prime Rep       Date:  2014-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.